Bridgebio Pharma Inc (BBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -653,251 | -484,652 | -586,454 | -505,488 | -288,585 |
| Depreciation Amortization | 6,494 | 6,771 | 5,843 | 1,456 | 859 |
| Accounts payable and accrued liabilities | 2,780 | -349 | 2,833 | -735 | -4,657 |
| Other Working Capital | 5,057 | 28,079 | -4,396 | 14,934 | -10,915 |
| Other Operating Activity | 111,200 | 30,657 | 84,240 | 90,119 | 49,711 |
| Operating Cash Flow | $-527,720 | $-419,494 | $-497,934 | $-399,714 | $-253,587 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,306 | -4,821 | -13,246 | -7,518 | -2,638 |
| Purchase Of Investment | -137,264 | -193,055 | -643,275 | -287,852 | -212,899 |
| Sale Of Investment | 193,106 | 532,523 | 477,041 | 249,137 | N/A |
| Purchase Sale Intangibles | N/A | -1,500 | -35,000 | N/A | N/A |
| Other Investing Activity | -503 | 118,500 | -21,346 | -6,760 | -1,716 |
| Investing Cash Flow | $54,033 | $453,147 | $-200,826 | $-52,993 | $-217,253 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 747,500 | N/A | N/A |
| Debt Issued | N/A | N/A | 456,296 | 550,000 | 36,939 |
| Debt Repayment | N/A | -20,486 | -124,119 | N/A | N/A |
| Common Stock Issued | 459,216 | 8,076 | 20,464 | 38,222 | 416,182 |
| Common Stock Repurchased | -6,880 | -1,561 | -266,041 | -124,994 | N/A |
| Other Financing Activity | -801 | 837 | -97,654 | -16,039 | -54,329 |
| Financing Cash Flow | $451,535 | $-13,134 | $736,446 | $447,189 | $398,792 |
| Beginning Cash Position | 416,884 | 396,365 | 358,679 | 364,197 | 436,245 |
| End Cash Position | 394,732 | 416,884 | 396,365 | 358,679 | 364,197 |
| Net Cash Flow | $-22,152 | $20,519 | $37,686 | $-5,518 | $-72,048 |
| Free Cash Flow | |||||
| Operating Cash Flow | -527,720 | -419,494 | -497,934 | -399,714 | -253,587 |
| Capital Expenditure | -1,306 | -4,821 | -13,246 | -7,518 | -2,638 |
| Free Cash Flow | -529,026 | -424,315 | -511,180 | -407,232 | -256,225 |